Fresenius SE & Co. KGaA
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FSNUF research report →
About the company
Fresenius SE & Co. KGaA is a diversified healthcare enterprise delivering a broad spectrum of products and services across multiple sectors, including dialysis, hospital operations, and outpatient medical treatment. Its operations are structured into four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.
- CEO
- Michael Sen
- IPO
- 2012
- Employees
- 175,202
- HQ
- Bad Homburg vor der Höhe, DE
Price Chart
- Market Cap
- $30.61B
- P/E
- 15.95
- P/S
- 1.04
- P/B
- 1.20
- EV/EBITDA
- 9.37
- Div Yield
- 2.47%
- Gross Margin
- 25.25%
- Op Margin
- 9.45%
- Net Margin
- 6.38%
- ROE
- 7.76%
- ROIC
- 4.54%
- Revenue
- $22.86B · 4.72%
- Net Income
- $1.26B · 168.26%
- EPS
- $2.25 · 167.86%
- Op Income
- $2.18B
- FCF YoY
- -21.42%
- 52W High
- $58.16
- 52W Low
- $46.21
- 50D MA
- $54.35
- 200D MA
- $54.89
- Beta
- 0.82
- Avg Volume
- 100.24
Get TickerSpark's AI analysis on FSNUF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FSNUF coverage
Recent articles, reports, and earnings notes.
No research on FSNUF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FSNUF report →Similar companies
Peers in the same neighborhood.